Total Payments
$8,335
2024 Payments
$2,464
Companies
32
Transactions
373
Medicare Patients
5,027
Medicare Billing
$317,926
Payment Breakdown by Category
Food & Beverage$7,869 (94.4%)
Education$465.48 (5.6%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $7,869 | 367 | 94.4% |
| Education | $465.48 | 6 | 5.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Regeneron Healthcare Solutions, Inc. | $1,903 | 45 | $0 (2024) |
| ABBVIE INC. | $1,079 | 52 | $0 (2024) |
| Lilly USA, LLC | $782.80 | 45 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $766.58 | 59 | $0 (2024) |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $631.72 | 27 | $0 (2024) |
| Janssen Biotech, Inc. | $608.74 | 27 | $0 (2024) |
| GENZYME CORPORATION | $374.14 | 10 | $0 (2024) |
| Dermavant Sciences, Inc. | $318.46 | 16 | $0 (2024) |
| PFIZER INC. | $297.42 | 8 | $0 (2024) |
| UCB, Inc. | $252.65 | 12 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,464 | 105 | Regeneron Healthcare Solutions, Inc. ($316.41) |
| 2023 | $2,003 | 84 | Regeneron Healthcare Solutions, Inc. ($655.05) |
| 2022 | $2,234 | 101 | Regeneron Healthcare Solutions, Inc. ($456.21) |
| 2021 | $1,634 | 83 | Regeneron Healthcare Solutions, Inc. ($475.27) |
All Payment Transactions
373 individual payment records from CMS Open Payments — Page 1 of 15
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $18.82 | General |
| 12/17/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $22.52 | General |
| Category: Immunology | ||||||
| 12/17/2024 | PFIZER INC. | EUCRISA (Drug), CIBINQO, LITFULO | Food and Beverage | In-kind items and services | $18.19 | General |
| Category: DERMATOLOGY | ||||||
| 12/14/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $15.73 | General |
| Category: DERMATOLOGY | ||||||
| 12/12/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $32.80 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 12/10/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $22.28 | General |
| Category: DERMATOLOGY | ||||||
| 12/04/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | ILUMYA (Biological) | Food and Beverage | In-kind items and services | $29.47 | General |
| Category: Dermatology | ||||||
| 12/03/2024 | Lilly USA, LLC | EBGLYSS (Drug) | Food and Beverage | In-kind items and services | $10.82 | General |
| Category: Immunology | ||||||
| 11/27/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $16.37 | General |
| Category: Dermatology | ||||||
| 11/21/2024 | PFIZER INC. | EUCRISA (Drug), CIBINQO, LITFULO | Food and Beverage | In-kind items and services | $22.53 | General |
| Category: DERMATOLOGY | ||||||
| 11/20/2024 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $13.97 | General |
| Category: DERMATOLOGY | ||||||
| 11/19/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $20.58 | General |
| Category: IMMUNOLOGY | ||||||
| 11/19/2024 | Lilly USA, LLC | EBGLYSS (Drug) | Food and Beverage | In-kind items and services | $13.73 | General |
| Category: Immunology | ||||||
| 11/14/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Education | In-kind items and services | $99.00 | General |
| Category: Immunology | ||||||
| 11/14/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $28.65 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 11/13/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $23.55 | General |
| Category: Dermatology | ||||||
| 11/11/2024 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $21.67 | General |
| Category: IMMUNOLOGY | ||||||
| 11/07/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | ILUMYA (Biological) | Food and Beverage | In-kind items and services | $23.41 | General |
| Category: Dermatology | ||||||
| 11/06/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $22.03 | General |
| Category: DERMATOLOGY | ||||||
| 11/05/2024 | Lilly USA, LLC | EBGLYSS (Drug) | Food and Beverage | In-kind items and services | $14.21 | General |
| Category: Immunology | ||||||
| 10/31/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $16.85 | General |
| Category: IMMUNOLOGY | ||||||
| 10/30/2024 | Paratek Pharmaceuticals, Inc. | NUZYRA (Drug) | Food and Beverage | In-kind items and services | $16.90 | General |
| Category: ANTIBIOTIC | ||||||
| 10/24/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $28.65 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 10/24/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $6.91 | General |
| Category: DERMATOLOGY | ||||||
| 10/22/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $43.21 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 11 | 640 | 1,351 | $138,155 | $42,328 |
| 2022 | 20 | 1,880 | 3,975 | $338,113 | $118,196 |
| 2021 | 20 | 1,388 | 2,571 | $242,105 | $85,526 |
| 2020 | 15 | 1,119 | 2,069 | $202,235 | $71,876 |
Total Patients
5,027
Total Services
9,966
Medicare Billing
$317,926
Procedure Codes
66
All Medicare Procedures & Services
66 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 161 | 269 | $40,420 | $14,201 | 35.1% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 95 | 125 | $28,035 | $7,809 | 27.9% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 101 | 146 | $19,117 | $4,312 | 22.6% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 64 | 64 | $13,885 | $4,259 | 30.7% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 53 | 57 | $10,295 | $2,976 | 28.9% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 88 | 608 | $7,001 | $2,451 | 35.0% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2023 | 18 | 19 | $5,764 | $1,806 | 31.3% |
| 96573 | Application of light by qualified health care professional to destroy precancer skin growth | Office | 2023 | 12 | 12 | $4,632 | $1,452 | 31.4% |
| 11104 | Punch biopsy, first skin growth | Office | 2023 | 18 | 18 | $4,374 | $1,396 | 31.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 11 | 12 | $2,748 | $979.08 | 35.6% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 19 | 21 | $1,884 | $685.98 | 36.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 474 | 746 | $102,396 | $35,465 | 34.6% |
| J7308 | Aminolevulinic acid hcl for topical administration, 20%, single unit dosage form (354 mg) | Office | 2022 | 36 | 57 | $35,744 | $17,249 | 48.3% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 329 | 492 | $49,696 | $14,449 | 29.1% |
| 11104 | Punch biopsy, first skin growth | Office | 2022 | 174 | 195 | $37,081 | $12,883 | 34.7% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2022 | 132 | 172 | $29,105 | $9,513 | 32.7% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2022 | 283 | 1,812 | $18,408 | $6,894 | 37.5% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2022 | 37 | 39 | $9,907 | $3,805 | 38.4% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 73 | 73 | $12,643 | $3,657 | 28.9% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 105 | 123 | $10,408 | $3,383 | 32.5% |
| 96567 | Application of light to destroy precancer skin growth | Office | 2022 | 35 | 38 | $8,043 | $2,901 | 36.1% |
| 11105 | Punch biopsy, each additional skin growth | Office | 2022 | 37 | 49 | $4,361 | $1,803 | 41.3% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2022 | 35 | 35 | $5,551 | $1,585 | 28.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 22 | 24 | $4,657 | $1,570 | 33.7% |
| 11106 | Incision biopsy, first skin growth | Office | 2022 | 15 | 15 | $3,529 | $1,282 | 36.3% |
About Jay Passmore, MSN
Jay Passmore, MSN is a Flight healthcare provider based in Chattanooga, Tennessee. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/20/2015. The National Provider Identifier (NPI) number assigned to this provider is 1063804532.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Jay Passmore, MSN has received a total of $8,335 in payments from pharmaceutical and medical device companies, with $2,464 received in 2024. These payments were reported across 373 transactions from 32 companies. The most common payment nature is "Food and Beverage" ($7,869).
As a Medicare-enrolled provider, Passmore has provided services to 5,027 Medicare beneficiaries, totaling 9,966 services with total Medicare billing of $317,926. Data is available for 4 years (2020–2023), covering 66 distinct procedure/service records.
Ad
Practice Information
- Specialty Flight
- Other Specialties Nurse Practitioner
- Location Chattanooga, TN
- Active Since 02/20/2015
- Last Updated 12/13/2022
- Taxonomy Code 163WF0300X
- Entity Type Individual
- NPI Number 1063804532
Products in Payments
- DUPIXENT (Biological) $2,221
- TALTZ (Drug) $733.58
- SKYRIZI (Biological) $640.13
- TREMFYA (Drug) $484.83
- COSENTYX (Biological) $360.08
- ILUMYA (Biological) $343.57
- VTAMA (Drug) $318.46
- RINVOQ (Biological) $279.09
- OPZELURA (Drug) $201.21
- COSENTYX (Drug) $156.85
- LIBTAYO (Biological) $155.93
- Otezla (Drug) $146.81
- ADBRY (Biological) $145.90
- Cimzia (Drug) $143.59
- HUMIRA (Biological) $133.91
- EUCRISA (Drug) $125.01
- REMICADE (Biological) $123.91
- Bimzelx (Biological) $109.06
- LITFULO (Drug) $91.59
- SPEVIGO (Drug) $91.16
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.